Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

‘Battle for Health Justice’: Dr. Alakija Addresses Global Rheumatology Inequities

Ruth Jessen Hickman, MD  |  Issue: December 2021  |  November 10, 2021

He also pointed out that the global burden of disease is shifting, with the relative impact of premature mortality decreasing and the impact of disability increasing. This is pertinent to many areas of rheumatology, in which early diagnosis and adequate treatment can radically reduce an individual’s lifetime disability burden. But, according to Dr. Murray, many public health officials do not seem to be aware of this shift.

 “Health systems really need to adapt to the rise of [non-communicable diseases] and disabilities,” said Dr. Murray. “There has been a really profound shift—particularly in the middle [sociodemographic index] countries.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“But health systems don’t seem to keep up with the epidemiological shift. We’re seeing this problem, especially in the middle [sociodemographic index countries], where progress for delivering interventions for non-communicable diseases is much slower than the changes that you see,” he added. 

Young Leaders 

At another session, the Future of Rheumatology Around the Globe, several early career rheumatologists, representing the ACR, the Pan-American League of Associations for Rheumatology (PANLAR), the European Alliance of Associations for Rheumatology (EULAR), the African League Against Rheumatism (AFLAR) and the Asia Pacific League of Associations for Rheumatology (APLAR), shared their perspectives about some of the most important challenges facing the rheumatology community, including many issues surrounding access to care.

Dr. Uribe

Sebastián Herrera Uribe, MD, an associate professor of rheumatology at Universidad CES in Medellin, Colombia, noted that although rheumatologists and treatments could be found in his city, most rural communities lacked access to such care and may only be served by a nurse practitioner. Telemedicine can be a partial strategy to help deliver care to these areas, but it isn’t practical in every situation, he noted.

“We have to engage with local governments and local healthcare policy to bring rheumatology to the forefront,” Dr. Uribe added. “If we don’t participate and don’t do our advocacy work and don’t do the education part, both for our communities and for our governments, nobody will. And probably people who aren’t knowledgeable about rheumatology will make the decisions.”

Dr. Ima-Edomwonyi

The number of rheumatologists available is also a key challenge in his region, said Uyiekpen Ima-Edomwonyi, MD, a consultant rheumatologist at Lagos University Teaching Hospital, Nigeria. The rheumatologists who are available may become overburdened and burned out, he remarked. He emphasized the need to encourage more medical professionals to go into rheumatology while also aiding the support specialties to better assist in patient education and overall care.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsProfessional Topics Tagged with:ACR Convergence 2021International

Related Articles

    Prospects for Treating Patients with Arthritis in African Countries with Few Rheumatologists

    June 14, 2017

    At present, the U.S. has approximately 5,000 full-time adult rheumatologists. By the year 2025, that number will decline to roughly 3,600.1 Sounds dire, right? Hold that thought. Question: What country has 99 million people and no adult rheumatologists? ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAnswer: Ethiopia.2 The Nigerian Story And then there is Africa’s most populous country,…

    2015 ACR/ARHP Annual Meeting: Global Challenges in Rheumatic Disease Care

    April 15, 2016

    SAN FRANCISCO—To convey the plight of rheumatology patients in sub-Saharan Africa, Girish Mody, MD, head of rheumatology at the University of KwaZulu-Natal in South Africa and past president of the African League of Associations for Rheumatology, recounted a story during the 2015 ACR/ARHP Annual Meeting from the World Health Organization about a diabetes patient. The…

    A World of Difference: Updates from the Global Rheumatology Summit

    January 20, 2023

    The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences